Rights and permissions
About this article
Cite this article
Imatinib mesylate: best first-line pharmacotherapy for CML. Inpharma Wkly. 1379, 13 (2003). https://doi.org/10.2165/00128413-200313790-00024
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313790-00024